Table of Contents

1 Global Market Overview

• 1.1 Scope of Statistics
  • 1.1.1 Scope of Products
  • 1.1.2 Scope of Manufacturers
  • 1.1.3 Scope of Application
  • 1.1.5 Scope of Regions/Countries
• 1.2 Global Market Size

2 Regional Market

• 2.1 Regional Production
• 2.2 Regional Demand
• 2.3 Regional Trade

3 Key Manufacturers

• 3.1 BioTime, Inc.
  • 3.1.2 Company Information
  • 3.1.2 Product Specifications
  • 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.2 BrainStorm Cell Therapeutics
  • 3.2.1 Company Information
  • 3.2.2 Product Specifications
  • 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.3 Caladrius Biosciences, Inc.
  • 3.3.1 Company Information
  • 3.3.2 Product Specifications
  • 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.4 Fibrocell Science, Inc.
  • 3.4.1 Company Information
  • 3.4.2 Product Specifications
  • 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.5 Opexa Therapeutics, Inc.
  • 3.5.1 Company Information
  • 3.5.2 Product Specifications
  • 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.6 Pharmicell Co., Inc.
  • 3.6.1 Company Information
  • 3.6.2 Product Specifications
  • 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.7 Pharmicell Co., Inc.
  • 3.7.1 Company Information
  • 3.7.2 Product Specifications
  • 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.8 TiGenix NV
  • 3.8.1 Company Information
  • 3.8.2 Product Specifications
  • 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.9 TxCell SA
  • 3.9.1 Company Information
  • 3.9.2 Product Specifications
  • 3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.10 U.S. Stem Cell, Inc.
  • 3.10.1 Company Information
  • 3.10.2 Product Specifications
  • 3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.11 Vericel Corporation

4 Major Application

• 4.1 Neurology
  • 4.1.1 Overview
  • 4.1.2 Neurology Market Size and Forecast
• 4.2 Orthopedics
  • 4.2.1 Overview
  • 4.2.2 Orthopedics Market Size and Forecast
• 4.3 Cancer
  • 4.3.1 Overview
  • 4.3.2 Cancer Market Size and Forecast
• 4.4 Wound Healing
  • 4.4.1 Overview
  • 4.4.2 Wound Healing Market Size and Forecast
• 4.5 CVD
  • 4.5.1 Overview
  • 4.5.2 CVD Market Size and Forecast
• 4.6 Autoimmune
  • 4.6.1 Overview
  • 4.6.2 Autoimmune Market Size and Forecast
• 4.7 Autoimmune
  • 4.7.1 Overview
  • 4.7.2 Autoimmune Market Size and Forecast

5 Market by Type

• 5.1 Bone Marrow
  • 5.1.1 Overview
  • 5.1.2 Bone Marrow Market Size and Forecast
• 5.2 Epidermis
  • 5.2.1 Overview
  • 5.2.2 Epidermis Market Size and Forecast

6 Conclusion

Summary
The global Autologous Cell Therapy market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
BioTime, Inc. 
BrainStorm Cell Therapeutics 
Caladrius Biosciences, Inc. 
Fibrocell Science, Inc. 
Opexa Therapeutics, Inc. 
Pharmicell Co., Inc. 
Pharmicell Co., Inc. 
TiGenix NV 
TxCell SA 
U.S. Stem Cell, Inc. 
Vericel Corporation
Major applications as follows:
Neurology 
Orthopedics 
Cancer 
Wound Healing 
CVD 
Autoimmune 
Autoimmune 
Major Type as follows:
Bone Marrow 
Epidermis
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa